Innova Captab

Innova Captab Goodwill

The Goodwill of Innova Captab (INNOVACAP.NS) as of Nov 22, 2026 is 166.94 M INR. In the previous year, Goodwill was 166.94 M INR — a change of 0.00% (lower).

Goodwill

166.94 MINR

YoY

0.00%

Last updated:

Goodwill of Innova Captab is 2026 166.94 M INR. Goodwill of Innova Captab was 2025 166.94 M INR. It decreases by 0.00% lower compared to the previous year.

The Innova Captab Goodwill history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill
Date
Goodwill
Jan 1, 2019
166.94 M INR
Jan 1, 2020
166.94 M INR
Jan 1, 2021
0.00 INR
Jan 1, 2022
166.94 M INR
Jan 1, 2023
166.94 M INR
Jan 1, 2024
166.94 M INR
Jan 1, 2025
166.94 M INR
Jan 1, 2026
166.94 M INR
The Innova Captab Goodwill history
YEARGoodwillYoY
166.94 MINR0.00%
166.94 MINR0.00%
166.94 MINR0.00%
166.94 MINR0.00%
166.94 MINR—
0.00INR-100.00%
166.94 MINR0.00%
166.94 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innova Captab Stock analysis

What does Innova Captab do? Innova Captab Ltd generates revenue through its CDMO business, which offers research, product development, and manufacturing services to clients in the pharmaceutical sector. The company also earns from its domestic branded generics business, developing, manufacturing, and distributing generic formulation products under its own brand names across India via online and offline channels. Additionally, Innova Captab sells its generic drug products through various e-commerce pharmacy sites. The company's diversified portfolio includes tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. Its international branded generic product business focuses on exporting branded generic products globally. Innova Captab's primary customers are pharmaceutical companies seeking CDMO services, Indian consumers purchasing generic medicines through retail and online pharmacies, and international buyers of branded generic products. The domestic market segment is served through branded generics sold under the company's own brand names, while the international segment targets global markets for branded generic drug exports. The company's value chain spans research and development, manufacturing, drug distribution, marketing, and exports, ensuring comprehensive coverage across the pharmaceutical industry. The company's product segments include CDMO services, domestic branded generics, and international branded generics. CDMO services are provided to pharmaceutical firms requiring outsourced research and manufacturing. Domestic branded generics are marketed in India under the company's brand names through both online and offline channels. International branded generics are exported to global markets, leveraging the company's manufacturing capabilities and product portfolio. Innova Captab's business model integrates all stages of the pharmaceutical value chain, from R&D to exports, to deliver a full-service solution for its clients and customers. Innova Captab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Innova Captab stock

Goodwill of Innova Captab is 166.94 M INR in 2026.

Goodwill of Innova Captab changed from 166.94 M INR to 166.94 M INR, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill Innova Captab since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's Innova Captab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Innova Captab

All Key Metrics — Innova Captab